TGFβ signaling plays an important role in mesenchymal transition in cancer, and TGFβ1/3 and TβRII are the three TGFβ signaling genes within the list of 840 transcriptomic signature genes that are used to classify GBM subtypes. Here, TGFBR2 is linked to cancer.